Yes, nanotechnology can significantly enhance gene therapy approaches for DMD. One promising strategy involves using nanoparticles to deliver CRISPR/Cas9 components, which can precisely edit the dystrophin gene. By correcting the genetic mutations responsible for DMD, this approach holds the potential for a long-lasting cure.
